Ascendis Pharma A/S of HELLERUP, G7, a company, filed a Form D exempt-offering notice with the SEC on 2014-12-09. The offering totals $60.0M, of which $60.0M was reported sold. Industry: Pharmaceuticals.
| Name | Role | Location |
|---|---|---|
| Albert Wolff Cha | Director | Hellerup, G7 |
| Edwin Wolff de Graaf | Director | Hellerup, G7 |
| James Wolff Healy | Director | Hellerup, G7 |
| Michael Wolff Jensen | Director | Hellerup, G7 |
| Michael Wolff Mayer | Director | Hellerup, G7 |
| Jan Mller Mikkelsen | Director | Hellerup, G7 |
| Martin Wolff Olin | Director | Hellerup, G7 |
| Jonathan Wolff Silverstein | Director | Hellerup, G7 |
| Rafa?le Wolff Tordjman | Director | Hellerup, G7 |
| Martin Wolff Auster | Executive Officer | Hellerup, G7 |
| Michael Wolff Jensen | Executive Officer | Hellerup, G7 |
| Jan Mller Mikkelsen | Executive Officer | Hellerup, G7 |
| Grethe Wolff Rasmussen | Executive Officer | Hellerup, G7 |
| Harald Wolff Rau | Executive Officer | Hellerup, G7 |
| Lotte Wolff S?nderbjerg | Executive Officer | Hellerup, G7 |
| Thomas Wolff Soloway | Executive Officer | Hellerup, G7 |